# Pioglitazone and Quetiapine XR Pharmacogenetic Study

> **NCT01342380** · — · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 42 (actual)

## Conditions studied

- Bipolar Disorder
- Major Depressive Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01342380
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-07-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342380, "Pioglitazone and Quetiapine XR Pharmacogenetic Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01342380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*